multicellular communities and their role in infectious diseases. Biofilms can thrive on virtually any surface and can be beneficial or detrimental based upon the community's interplay and the surface. Advances in the understanding of structural and functional variations and the roles that biofilms play in disease and host-pathogen interactions have been addressed through comprehensive literature searches. In this review article, a synopsis of the methodological landscape of biofilm analysis is provided, including an evaluation of the current trends in methodological research. We deem this worthwhile because a keyword-oriented bibliographical search reveals that less than 5% of the biofilm literature is devoted to methodology. In this report, we (i) summarize current methodologies for biofilm characterization, monitoring, and quantification; (ii) discuss advances in the discovery of effective imaging and sensing tools and modalities; (iii) provide an overview of tailored animal models that assess features of biofilm infections; and (iv) make recommendations defining the most appropriate methodological tools for clinical settings.
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INTRODUCTION B
iofilms are multidimensional communities in which resident bacteria coexist within the self-derived extracellular matrix (ECM) (1, 2) . Although the developmental stages leading to biofilm formation appear to be conserved ( Fig. 1 ), every species (or consortium of species in the case of polymicrobial biofilms) forms a unique multicellular community (3, 4) . This protected network possesses the ability to evade environmental threats, such as antimicrobials and host defense mechanisms (5) .
Biofilms account for 80% of chronic microbial human infections, leading to increased rates of hospitalization, elevated health care costs, and increased mortality and morbidity rates (6) . Upper and lower respiratory tract diseases, native valve endocarditis, chronic otitis media, eye infections, chronic wounds, diabetic foot ulcers, urinary tract infections (UTIs), and periodontitis are all biofilm-associated diseases (7) (8) (9) (10) (11) (12) . Biofilms can also develop on abiotic surfaces, including medical devices such as orthopedic prostheses, artificial cardiac valves, coronary stents, intravascular and urinary catheters, neurosurgical, cochlear, and breast implants, dentures, and ventricularassist and ocular devices (13) .
Since the term "biofilm" was introduced in 1978, the intrigue and excitement surrounding a new microbiological field of study have produced opportunities of environmental, industrial, and clinical importance (14) . Biofilms made a global impact in the literature, and their study continues to generate more questions. Because of the mechanical, physicochemical, microbiological, and medical components of biofilms, different disciplines views biofilms from different perspectives: chemists focus on organized chemicals, physicists deal with thermodynamics, and biologists examine the microbial physiology that affects biofilm formation and also unravel resistance patterns, yet all are left with the question of how all these components comprise the biofilmassociated threat. The unique nature of biofilm communities within the context of infection makes the constant development of new strategies acting against biofilms, as well as architectural and behavioral investigations, an evolving necessity (15) . The last decade has seen a multitude of diverse methodological tools and enabled a context for comparative use and analysis that follows the rationale that biofilms thrive on living and inanimate surfaces by adaption and survival. Their versatile behavior leads to extended (by design) experimental diversity and subsequently confounds efforts to evaluate biofilm-specific in vitro antimicrobial susceptibility. For the methodological piece alone, it should be noted that the risk of erroneous data acquisition is significant and that limited accuracy and reproducibility of viability assays have been recorded (16, 17) . This description fails to capture the inconvenient reality. Dye aggregates will not bind stoichiometrically to complex communities (18) . Microscopic enumerations, by default, provide indirect population assessments. Conventional colony formation assays bacteria grown in liquid cultures (42-47). Surface-associated biofilms are highly dependent on the substratum material and may or may not be exposed to air. Among the most common materials that promote biofilm formation on abiotic substrata are polyvinyl chloride (PVC), silicone, polystyrene, and metal (48-50). In microbial keratitis, for example, P. aeruginosa exhibits preferential adhesion to polymeric contact lenses (51), while in urinary catheters bacteria are preferably adherent to silicone and PVC biomaterials (52). As far as air exposure is concerned, the acquisition of antimicrobial resistance (AMR) and tolerance to xenobiotics has been attributed to (i) adequate oxygenation required for bacterial metabolism and (ii) facilitated DNA exchange due to the juxtaposed distribution of the bacterial cells in the well-organized biofilm cluster at the air-liquid interface (53).
Apart from surface composition, surface coatings can also play a role in biofilm formation. Blood components (fibrin, laminin, collagen, fibronectin, and immunoglobulins) compose the fibrin sheath that fosters the adherent growth mode around and into the air-deprived lumen of central venous catheters (CVC). Although results from both in vitro and in vivo studies regarding fibrin sheath-coated surfaces are inconsistent, reports of enhanced incidence of persistent bacteremia confirm the biofilm formation attributed to fibrin coating for some species (54).
Biofilms that take up nutrients directly from the surface to which they adhere (such as bacterial colonies on agar plates) are highly dependent on the substratum material (55, 56). In this case, the community grows outwards from the center of the colony, and architectural complexity most likely increases in response to nutrient and other environmental gradients that are created over time (45, 55, 56) . Among these biofilms are the type called pellicles, which have been described as floating biofilms formed on a liquid surface (Fig. 2B) (42) . Examples of bacteria that form liquid surface-associated pellicles include different strains of E. coli and Salmonella spp. (23, (57) (58) (59) . This type of biofilm exhibits various degrees of meniscus growth, strength, and structure and possesses matrix-embedding, host-derived extracellular polymeric substance (EPS) components, laying the foundation for involvement in clinically relevant conditions (29, 60, 61) . The liquid substratum provides the primary source of nutrients for the growing community. The term "pellicle" has also been used for dental diseases caused by biofilms formed from multicellular aggregates that require saliva proteins for attachment (62, 63) .
Submerged Biofilms
In addition to surface-associated biofilms, bacteria can form submerged biofilms under both static and shear-flow conditions. These types of biofilms are perhaps the most relevant in most chronic infectious disease states, as most of the deviceassociated infections involve the formation of submerged biofilms. Pathogenic biofilms formed on all types of catheters, including urinary and central/peripheral venous access lines, endotracheal and nasogastric tubes, and cerebrospinal fluid shunts, as well as on artificial cardiac valves, are examples of multicellular communities developing under variable-flow conditions (Fig. 2C) (64, 65) . In catheters of all types, bacteria are introduced from the outside environment into the catheter lumen during catheter insertion and can swim or are carried by normal fluid flow. Bacteria then attach to the abiotic material by using adhesive fibers. Host biomolecules, such as fibrinogen, laminin, collagen, and fibronectin, also serve as platforms for bacterial adherence, as they become deposited on the surface in both central venous and urinary catheters shortly after insertion of the device (62, 66) . Bacterial expansion upon adherence leads to the formation of the biofilm community, a process known as maturation.
Laminar/semilaminar flow (implicated in biofilm formation in blood vessels), turbulent fluid mechanics (characterizing prosthetic valves), and discontinuous trickle (referring to catheter-associated UTIs [CAUTIs] ) are several examples of fluid flow dynamics (67) (68) (69) . For each condition, suitably adapted lab devices that contain simultaneous growth medium supply and waste removal are developed. These flow systems create optimal conditions for the generation of mature biofilms. Culture preparation, surface conditioning, and adjusted methods provide lab substrates mimicking clinical conditions. A characteristic example involves the evaluation of four CVC Staphylococcus epidermidis biofilm infection models that differ in material type (glass versus polymer) and nutrient presentation (static versus continuous flow) (70) .
Roots of Biofilm Phenotypic Resistance
The biofilm life cycle ends with the dispersal of bacterial cells stemming from the biomass after maturation (71) . The dissemination and colonization of new target sites explain recalcitrant chronic infections within the host; biofilm-originating cells form bacterial niches with resistance phenotypes at the newly colonized sites. The biofilm dispersal process is controlled by environmental signals (oxygen, nutrients, temperature, and signaling molecules), intracellular reduction of the concentration of c-di-GMP, and upregulation of motility or quorum sensing (QS) genes, though many bacterial dispersal signals remain cryptic (13, 72, 73) .
A single clonal population alters the growth rate and turns on adaptive pathways due to multiple environmental signals. The study of this complex yet distinct adaptation process elucidates changes in chronicity that contribute to fitness without being limited to specialized cells and signals (74) . Since the environmental gradients surrounding the microbial community influence biofilm composition, phenotypically distinct subpopulations arise, including extracellular matrix producers, adhesive fiber producers, motile bacteria, and metabolically quiescent and/or antibiotic-tolerant bacteria (23, 24, 75, 76) . Persisters emerge through diverse cellular and molecular phenomena, including biofilm matrix protection against the host immune system, redundant toxin-antitoxin (TA) modules induced by DNA damage (SOS response), nutrient elimination, the age of the inoculum, and the downregulation of genes related to motility, cell division, and protein synthesis (77) (78) (79) . The quiescent phenotype is actively present in chronic and recalcitrant infections surviving under antibiotic pressure. For example, the reversible overexpression of the HipA and RelE toxins has been implicated in the interruption of cellular functional processes in E. coli under stress. Hence, persisters prevail without multiplying or being killed, exhibiting tolerance but not resistance, and therefore do not qualify as mutants (80, 81) . The slow-growing small-colony variant (SCV) subpopulation is another equally puzzling phenotype that complicates biofilm formation as well as treatment and diagnosis of biofilm-related disease. The contribution of SCVs to biofilm formation has been studied for a rather small number of bacterial pathogens despite the huge clinical significance of persistent infections evading detection and complicating treatment (82, 83) . In combination, these different phenotypes within microbial communities give rise to an extremely resilient community that can withstand many stressors and shield the resident bacteria from eradication.
Adaptive and phenotypic biofilm variations generate hurdles for the overall investigation and understanding of infection mechanisms. The partitioning of one or many different bacterial species is an additional unknown in this equation. Multispecies populations generate dynamic consortia with unique interactions [pathogen(s)-pathogen(s), pathogen(s)-commensal, and pathogen(s)-host], metabolic requirements, and phenotypes, setting investigative limitations with respect to the in vivo clinical setup, infection pathogenicity, and response to treatment; on the other hand, monospecies biofilms constitute a minute fraction of both acute and chronic infections (84) . Inter-and intraspecies interactions based on species-specific virulence traits set the stage for a complex microenvironment in which bacteria can exchange genetic markers and compete or cooperate for resources. The interplay among multiple pathogenic species enhances horizontal gene transfer of clinically prevailing phenotypic resistance elements. A fundamental trait of pluralism in biofilm composition is based upon the presence and content of nonbacterial elements. Examples of bacterial-fungal cooperation within the protected environment of a biofilm include that in wounds, the oral cavity, and urinary tract infections. This evolutionary tactic provides a stable survival equilibrium among kingdoms (85, 86) . Therefore, explaining the rationale for the clinical relevance of multispecies biofilms is not trivial. While multispecies biofilms are the most clinically relevant infections, their study has been the most limited due to the complexity of each community, the lack of knowledge regarding the identity and abundance of each biofilm resident, and the technical limitations associated with different biofilm setups. Examples include Haemophilus influenzae competing with Streptococcus pneumoniae, but not with Moraxella catarrhalis, in ear infections; Staphylococcus aureus and P. aeruginosa cooperating for survival in chronic wound infections; group B streptococci promoting survival of UPEC in UTIs; and Porphyromonas gingivalis and Treponema denticola exhibiting synergy in biofilm formation involved in periodontal disease (87) (88) (89) (90) (91) (92) .
Since the onset of the first biofilm studies, several technological advancements have greatly enhanced our ability to molecularly dissect biofilm architecture and characteristics both temporally and spatially. Below is a comprehensive review of the methodological landscape used for the study of biofilms, presenting a blend of classical and more recent technologies.
LABORATORY SETUPS
Cutting-edge points regarding technical information are discussed and the strengths and limitations of the most popular laboratory devices are provided in Table  1 . All biofilm species are not created equal, so they often require specific experimental conditions matching the developed methodological tools. Some tools are more practical and relevant than others, covering adherence, life in a "turbulent flow habitat," or the effect of coaggregation and flagellation on all types of bacteria.
Culturing Biofilms under Static Conditions
The complexity of colony biofilms on agar plates was overlooked for decades due to the lack of advanced methodologies to probe architecture differences (Fig. 3A) . This method generates a stable structure and limits the possibility of cell detachment, ensuring that observed differences in cell numbers are due to cell death rather than detachment (93) .
Microtiter plate-based assays were first described in 1985 for assessing staphylococcal adherence to plastic tissue culture plates (94) (Fig. 3B ). Bacterial inocula with standardized concentrations are placed in a 96-well microtiter plate made of PVC, polystyrene, or other material and incubated aerobically at 37°C for designated time frames (1 to 4 h for initial attachment and ϳ20 h for biofilm formation, depending on the species). Planktonic cells are removed by gentle washing, and the adherent cells are stained with crystal violet (CV) and quantified by spectrophotometry (95, 96) . Studies concerning biofilm-forming isolates have exhibited that motile bacteria, including flagellated E. coli, P. aeruginosa, Vibrio cholerae, and Salmonella enterica, tend to coaggregate at the air-liquid interface. In contrast, the nonmotile cocci, including enterococci (with the exception of the motile organisms Enterococcus casseliflavus and Enterococcus gallinarum) and staphylococci, form aggregates at the microtiter plate base (97) (98) (99) (100) (101) (102) . Microtiter plates with removable silicone or polystyrene disks at the bottom can serve as platforms to facilitate microscopic and molecular examinations (97) . An air-liquid assay enables qualitative analysis of biofilm formation through direct phase-contrast microscopic visualization of the early-stage bacterial aggregates in flat-bottomed wells (Fig. 3C) . Bacterial inocula placed in a 24-well flat-bottomed plate are incubated at an angle or coverslips are placed at an angle into wells for the appropriate incubation time; coverslips are washed and stained with crystal violet or with a fluorescent antibody against a species-specific antigen or a protein of choice. A conventional or fluorescence microscope can be used for biofilm visualization (93) . The sad (surface attachment defective)-associated reversible and irreversible attachment of P. aeruginosa was investigated by this assay to decipher the pseudomonal developmental shift from the planktonic to the biofilm state in the CF lung (103) . Biofilm formation on epithelial cells, assessed by the air-liquid method, served as an in vitro model of chronic rhinosinusitis due to P. aeruginosa PAO1 (104) .
The BioFilm ring test (BRT) is a newly available tool for the study of biofilm formation kinetics that was developed in the last decade. It detects biofilm formation in modified 96-well polystyrene microtiter plates by use of magnetic microbeads and a scanning plate reader (105) (Fig. 3D) . Biofilm-associated adherence is determined when beads remain scattered after the application of a magnetic field; in contrast, beads are immobilized in the center of the well bottom in the presence of planktonic cells (105, 106) . Examples of BRT biofilm formation kinetics include those of (i) the nontypeable H. influenzae (NTHi) strains isolated from body fluids (blood, sputum, and pleural and cerebrospinal fluid) of individuals with nonbacteremic, community-acquired pneumonia and chronic obstructive pulmonary disease (COPD) and from middle ear fluid of patients with otitis media; (ii) the S. aureus and S. epidermidis strains from acute and chronic osteomyelitis and infectious arthritis cases; and (iii) the P. aeruginosa strains from CF patient sputum samples (107) (108) (109) (110) . A recent extension of BRT is Antibiofilmogram, which is used for susceptibility profile testing of bone and joint infection-related S. aureus biofilms with 11 widely used antibiotics. This method aims to facilitate therapeutic choices by narrowing the window of truly efficient antibiofilm treatment options (111) .
Culturing Biofilms under Flow Conditions
Continuous-flow cultures enable the formation of mature biofilms in chambers covered with coverslips or on silicone or latex tubes fitted to a peristaltic or syringe pump. The peristaltic pump facilitates flow of fresh growth medium, whereas planktonic cells and waste are removed. The biofilm formed is monitored microscopically after introducing fluorescent proteins or reporter genes (112) . Reporter genes are informative for the stage-specific physiological changes that occur under dynamic conditions and differentiate biofilms from their planktonic counterparts (21, 23, 113) . Green fluorescent protein (GFP) serves as an example of the reporter signals associated with the csgBA genes, which have been used extensively in biofilm interventions for UPEC (23).
Among the advantages of continuous-flow models is the ability to compare the effects that different media, oxygen concentrations, temperature shifts, and substances exert on a biofilm at all developmental phases. These models also offer evaluation of the effects that transiently occurring molecules, such as antibiotics or adherence inhibitors, have on biofilms. However, the technical disadvantages of continuous-flow biofilms include increased experimental complexity as well as possible formation/ trapping of air bubbles in the setup tubing. This can perturb proper medium flow, affect the architecture, and put the system at risk for contamination (114, 115) .
The Kadouri system is an intermediate system between static biofilms and low-flow cells (Fig. 3E) . The major difference from static assays is that the wells are part of a closed system with two outputs, one for the continuous fresh medium supply via an adjusted pump and one for the removal of waste and planktonic cells, while the difference from flow-cell systems lies in the minimal shear forces (93, 116) .
Drip-flow cell reactors enable biofilm formation in the air-liquid interface at low shear forces (117) (Fig. 3F) . A biofilm is formed in channels (mainly silicon tubes) containing glass coupons or catheters, and a large biomass is produced (20, 22, 61) . An in vitro model has been applied for bacteriophage-based bacterial biofilm inhibition on medical device surfaces. This model involved S. epidermidis biofilms on hydrogel-coated urinary and central venous catheters with a modified drip-flow biofilm reactor; the modification was a shift from drip to constant flow (118) .
The Robbins device (RD) generates submerged biofilms growing in aqueous systems that can be used for the interrogation of multispecies communities (119, 120) . Culturing multispecies biofilms in vitro can become complex regarding the microenvironment simulations. At present, multispecies biofilms are formed either by coculture of different preacquired clinical strains or by transfer of a mixed environmental population into the experimental setup (121) . So far, the most commonly applied device is the modified Robbins device (MRD) (Fig. 3G ), involving mono-or multispecies biofilm formation on catheter segments of various materials under flow conditions. Thus, MRD enables real-life biofilm simulation on catheter surfaces and is considered amenable for in vivo evaluation of implanted devices and catheters (14, 122, 123) . This setup has been applied for biofilm therapeutic interventions, including pharmaceutical preparations, such as minocycline and EDTA (M-EDTA), as well as the maintenance of catheter lumen patency and bacteriophage therapy for biofilm-related infections in CF patients (124, 125) .
Rotating-disk reactors, including the CDC biofilm reactor, facilitate growth under controlled moderate shear stress and continuous-medium-flow conditions (126) (Fig.  3H) . The reactor consists of a disk that rotates over a magnetic base and coupons of various materials that promote biofilm growth. A glass reactor vessel enables medium supply and waste removal; coupon removal at desired intervals is feasible (126) . An alternative method involves concentric reaction chambers with cylinders enabling biofilm formation. Modifications in speed or the cylinder's diameter affect the cell density and biofilm structure (127, 128) . Rotating-disk reactors enable antimicrobial agent and antifouling material efficacy, and the removable disks serve as testing surfaces for antibiofilm compounds (21) .
The peg lid Calgary biofilm device (CBD) generates biofilms on the bottoms of 96 pegs fitted in a polystyrene microplate lid or a multichannel tray containing a bacterial inoculum of a standardized optical density (Fig. 3I) . Pegs are then sealed and incubated on a rocking table that creates shear forces at a specific temperature for a specific time. Planktonic cells are rinsed off, and biofilms are detached from the pegs by sonication and then placed into sterile 96-well microtiter plates with specific dilutions of the tested biocide to estimate the minimum biofilm eradication concentration (MBEC) after 24 h of incubation (129, 130) . The study of sputum biofilm-forming P. aeruginosa strains isolated from CF patients is one example of CBD being used to compare the efficacies of multiple antibiotic combinations (131, 132) .
Microfermentors use slides of various materials as the substrate to form bacterial communities, while a constant medium flow and sterile air supply are provided (5, 133, 134) (Fig. 3J) . The large mass of biofilm generated through this assay provides information not only about the biofilm-forming ability of the tested strains but also about the antimicrobial susceptibility profile (5, 134) . Methicillin-resistant S. aureus (MRSA) strains appear to switch between proteinaceous and exopolysaccharidic biofilm matrices according to the provided substrate and environmental conditions in microfermentors (135) .
Microfluidics-based devices, including the relatively recent BioFlux device, are fully integrated platforms consisting of modified 96-well plates with laminar flow chambers, a shear-flow control system, an imaging system, and advanced software for data collection and analysis (Fig. 3K) . Microfluidic channels enable fresh medium movement due to pneumatic pressure at a controlled flow rate, rolling velocity, and time. Antimicrobial agents can be delivered to the flow biofilms from the inlet to the outlet well. In high-throughput (HT) flow-cell biofilm viability assays, viable cells are quantified by epifluorescence microscopy coupled with chemical or genetic color coding; highquality images are attributed to coverslip glass at the bottom of the wells (136) . Modifications involving protocol adaptations (temperature, medium type, and concentrations) and supplemental accessories (software packages and modules) extend microfluidic applications by facilitating complex assays and multiple experiments (137) . Examples of the use of microfluidics-based devices adapted for coculturing eukaryotic cell lines with bacterial aggregates include the study of HeLa cells with enterohemorrhagic E. coli (EHEC) and commensal biofilms to demonstrate the developmental events in a gastrointestinal (GI) tract infection (138) . Another example provided real-time monitoring of osteoblast adhesion and viability on the Ti alloy surfaces of orthopedic implants infected with S. epidermidis (139) .
Most of the existing lab setups for monospecies or multispecies bacterial biofilm formation also serve for biofilm-mammalian cell coculture systems. Both static and flow coculture biofilm model systems have been applied to study biofilm formation on biotic surfaces as well as the responses to various therapeutic approaches (140) . These models aim to reflect the infectious process in real time and offer the advantage of examining the host-pathogen interaction. Various culture systems have been employed in biofilm-mammalian cell coculture models, including (i) human airway epithelial cells (CFBE cells) and human bronchial epithelial cells (BEAS-2B) cocultured with P. aeruginosa (140) (141) (142) ; (ii) a human oral keratinocyte cell line cocultured with multispecies oral biofilms involving P. gingivalis, Fusobacterium nucleatum, Aggregatibacter actinomycetemcomitans, Streptococcus mitis, Streptococcus oralis, Streptococcus intermedius, Veillonella dispar, Actinomyces naeslundii, and Prevotella intermedia (143, 144) ; (iii) intestinal epithelial cells cocultured with E. coli O157:H7 (145); and (iv) human osteoblasts cocultured with Staphylococcus epidermidis (146) .
QUANTITATION AND VIABILITY ASSAYS
Static experimental conditions and a discontinuous nutrient supply are limiting factors in assessing mature biofilms in a lab setting (147) . Monitoring the viable bacteria within a biofilm can be achieved through (i) cultivation, (ii) metabolic activity detection, and (iii) membrane integrity evaluation. Conventional CFU enumeration fails to generate reproducibly reliable results for most biofilm quantification due to the presence of cell aggregates hampering distinct colony development as well as individual-species resolution, in the case of multispecies biofilms. Furthermore, vortexing or sonication before plating may lead to sample structure destruction or air bubble entrapment and erroneous results due to partial cell detachment (2, 148) .
The crystal violet (CV) assay, one of the most commonly used in vitro biofilmassociated techniques (Table 2) , enables optical visualization of biofilm thickness and optical computed tomography; TEM, transmission electron microscopy; SEM, scanning electron microscopy; ESEM, environmental scanning electron microscopy; ASEM, atmospheric scanning electron microscopy; EDS, energy-dispersive X-ray spectroscopy; EPS, extracellular polymeric substances; STXM, scanning transmission X-ray microscopy; AFM, atomic force microscopy; CRM, confocal resonance microscopy; MALDI-IMS, matrixassisted laser desorption ionization-imaging mass spectrometry; SIMS, secondary ion mass spectrometry.
Bacterial Biofilm Infection Methodology Clinical Microbiology Reviews total biofilm biomass quantification, especially in the initial stages, but is not accurate for calculating cell viability (24). Additionally, CV lacks sensitivity and specificity due to high variability when the dye (i) binds unspecifically to negatively charged molecules or (ii) is unevenly extracted by ethanol. The Congo red agar method investigates coagulase-negative staphylococcus (CoNS) strains for the production of slime and qualitatively scores cellulose and amyloid fiber production by Gram-negative bacteria (tested predominantly in E. coli, P. aeruginosa, and Salmonella) (149) (150) (151) (152) (153) . Dimethylmethylene blue (DMMB) binds to glycosaminoglycans (GAG) and polysaccharide intercellular adhesins (PIA). This is a species-specific method targeting S. aureus biofilms, restraining the diagnostic range of the technique to this PIA-related biofilm matrixpossessing species (154) . The Live/Dead BacLight assay uses double staining with the fluorescent nucleic acid dyes Syto 9 and propidium iodide (PI). Syto 9 fluoresces green and penetrates both damaged and intact cell membranes, providing total cell counts, while PI fluoresces red and crosses only damaged cell membranes. The dual presence of the dyes enables multimodal measurements, including microplate readings, flow cytometry analysis, and even microscopy. Indeed, in flow cytometry studies addressing antimicrobial agent testing for MIC determination, the dual usage of Syto 9 and PI required no preparatory stages. Drawbacks of the green fluorophore, including bleaching, ranging binding affinities (as in the case of Gram-negative bacteria), and background cross-signals, undermine the utility of Syto 9, thus welcoming the combination with PI. Additionally, the pronounced ability of PI to intercalate with DNA results in enhanced fluorescence, displacing Syto 9 and interfering with cell viability testing (155) . The large sample requirement makes the method time-consuming and unfit for HT assays (147) . Fluorescence-activated cell sorting (FACS) has been investigated intensively for the separation of biofilm subpopulations in the lab, with the potential to be deployed for quantification; reliable single-cell isolation of bacterial cells, on a scale orders of magnitude smaller than what mammalian cell flow systems are commonly designed to provide, remains a confounding factor in many cases (156) .
Other nucleic acid-binding dyes applied for fluorescence microscopy include acridine orange (AO), a cell-permeating dye that enables total counts of cells within the biomass; ethidium bromide (EB), which stains nucleic acids red when the integrity of the cell membrane is lost; and the DNA-specific probe DAPI (4=,6-diamidino-2-phenylindole), which stains cells with intact membranes (157) (158) (159) . The concept of dual-dye flow cytometric cell determination was introduced by use of a customized lab-built device employing a violet diode laser (397 nm) that excites fluorescence of both DAPI and Hoechst dyes in permeabilized and intact cells. Despite the fluorophore complications, flow cytometry is unique for the study of heterogeneous subpopulations (160) . A high DAPI concentration is indicative of a thicker biofilm; therefore, it can be used for biofilm extracellular matrix component detection and visualization. Such an example of DAPI implementation is the matrix analysis of Salmonella enterica serovar Typhi-and S. Typhimurium-associated gallstones (161).
2,3-Bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) is used to spectrophotometrically identify metabolically active cells that reduce XTT to water-soluble formazan (162) . However, it requires bacteria with high levels of aerobic metabolism and exhibits intra-and interspecies variability due to biofilm heterogeneity (30). The resazurin dye, also known as alamarBlue (AB), fluoresces and can be measured via spectrophotometry. In fact, resazurin is a nonfluorescent blue redox indicator that is reduced to the pink fluorescent compound resorufin through cellular respiration (163, 164) .
Oxidized 5-cyano-2,3-ditolyl tetrazolium chloride (CTC) dissolves in water, and the electron transport chain of metabolically active cells reduces CTC to fluorescent formazan crystals (165) . The incubation time and the CTC concentration affect the number of detectable cells, so this method is suitable only for estimating the number of highly metabolically active cells and only for aerobic or microaerophilic systems (166) .
The biotimer assay (BTA) measures metabolism by estimating the time needed for the visualized color change of specific indicators (phenol red and resazurin) with respect to the initial bacterial concentration according to correlation curves for planktonic bacteria (167) . The BTA is a rather simple and convenient colorimetric tool for biofilm susceptibility determination without requiring particular lab equipment. Fluorescein diacetate (FDA) emits yellow fluorescence once it is hydrolyzed by esterases. Although it is used to reproducibly measure microbial activity and biofilm biomass, it is unable to reach deep into thick biofilms (162, 168) .
"GRIND AND FIND" APPROACH VIA MOLECULAR ANALYSIS
Multispecies biofilm interrogation requires advanced molecular methodologies that enable species discrimination and strain-specific probes highlighting spatial distribution through advanced microscopy ( Table 2) . Additionally, surface cell attachment and phenotypic variation are initiated and influenced by specific on/off switch genes. Wild-type strains, isogenic mutants, and plasmids are constructed and studied with molecular assays to further specify and recognize genetic factors involved in biofilm formation. For example, the ica gene cluster was found to mediate PIA production, whereas the reversible insertion/excision of the IS256 sequence element has a strong correlation with phase variation/phenotypic switching of staphylococcal strains (169) (170) (171) (172) (173) .
PCR-based approaches as well as transcriptional and proteomic profiling can be used to interrogate gene expression differences occurring among free-living and sessile species. Genetic virulence traits are associated with phenotypic shifts contributing to the pathogenesis of clinically relevant strains. Genome sequences for adhesion proteins, tissue-penetrating enzymes, and toxins have been studied extensively for human biofilm-forming colonizers, such as MRSA, enterococcal, Acinetobacter baumannii, and K. pneumoniae strains (174) . Alterations in the expression of transmissibility, QS, and oxidative stress regulatory genes affect the survival of pseudomonal strains in CF patients, and genetic modifications affecting the biofilm-associated pneumococcal phenotype lead to a shift from asymptomatic carriage to nasopharyngeal pathogenesis (175) .
Early microarray analysis revealed that during the formation of E. coli biofilms and subsequent colonization, 38% of genes were modified, resulting in the altered expression of 600 genes (176) . Similar to microarray analyses, quantitative real-time PCR (qPCR) examines a subset of genes from biofilm-isolated cells, while multiplex PCR detects multiple target sequences and is a useful tool for genetic analysis of polymicrobial/multispecies communities or gene polymorphisms (177) (178) (179) (Table 3) . PCR product detection and quantification are based on probe chemistry.
RNA sequencing (RNA-seq) analyses based on next-generation sequencing (NGS) are now replacing conventional microarrays and provide higher sensitivity and information pertaining to small noncoding RNAs actively participating in oral pathogen dysbiotic processes (180) . Additionally, RNA-seq-based transcriptomic analyses have provided a multitude of genes associated with biofilm formation by both Gram-positive and Gram-negative bacterial species (such as MRSA, Enterococcus faecalis, and P. aeruginosa) in clinical entities, including otitis media, CF, chronic wounds, and endodontic and indwelling device infections (181, 182) . NGS platforms provide massive parallel sequencing of DNA segments physically or artificially produced from a single sample. This allows time-efficient reading of entire genomes (whole-genome sequencing [WGS]) as well as identification and quantification of genomic sequences in a sample at the level of a single molecule (target sequencing or sequencing of multiple bacterial species and subpopulations).
NGS in combination with reverse transcription-PCR (RT-PCR) (whole-exome sequencing or RNA-seq) provides evidence for a sample transcriptome. This combinatorial approach does not require genetic sequences, thus worthily replacing microarrays. RNA-seq analyses revealed the proportion of the dormant cell subpopulation within the bacterial biomass of S. epidermidis and the coexistence of unknown bacterial species in oral cavity pathogenesis (183) (184) (185) (186) . The heterogeneous, noncrystalline, and insoluble biofilm extracellular matrix is a rather perplexing assembly. Proteomics has provided deeper knowledge by (i) giving insights into the protein profile determinants that regulate host-pathogen interactions as well as the virulence and pathogenicity traits of the menacing bacteria; (ii) answering substantial questions regarding the biofilm antimicrobial resistance phenotype, offering potential alternatives for rational drug design; and (iii) underpinning physiological differences from planktonic species (187) (188) (189) . Indeed, the use of proteomics has been substantiated by mass spectrometry (MS) to extend its utility beyond research in the field of diagnostics to clinically oriented infectious disease investigation, with particular emphasis on host-pathogen interactions (190, 191) . The coupled use of proteomics with MS was an amenable mapping approach in a landmark study of the microbial proteome and the human microbiome (192) . Moving one step further, metaproteomics constitutes a cutting-edge tool for the study of multispecies community interactions by means of cooperation and competitiveness and the ways that these relationships shape the microbial consortium. Metaproteomics also offers the ability to elucidate the metabolic signatures of multispecies biofilms, even for the unculturable bacteria that reside within biofilms but cannot be cultivated by classic microbiological means, potentially providing novel tools for drug design (189, 193, 194) .
Hydrogen nuclear magnetic resonance ( 1 H-NMR) has been deployed for proteomic chemical compositional biofilm analysis and exhibits wide applicability to single-and multispecies communities. A "sum-of-the-parts" method to examine E. coli amyloidintegrated biofilms aimed to determine the pristine biofilm ECM composition. NMR also allows principal chemical component analysis, supporting the identification of key features between methicillin-susceptible S. aureus (MSSA) planktonic and biofilm species. The phenotypic differences were attributed to the uptake of specific amino acids, lipid catabolism, fermentation of butanediol, and metabolism alterations ranging from the production of energy to the accumulation of cellular components a PIA, polysaccharide intercellular adhesion; TA, toxin-antitoxin system; AHL, acyl homoserine lactone; QS, quorum sensing; EPS, extracellular polymeric substances; LPS, lipopolysaccharides; CoNS, coagulase-negative staphylococci. Some genes were studied by use of more than one technique, as follows: *, studied with RT-PCR; **, studied with multiplex PCR; and ***, studied with real-time PCR. (195) . Structural and morphological properties are also characterized by 13 C-NMR, which groups carbon pools from a single intact ECM sample. This approach defined the chemical composition and protein content of Vibrio cholerae biofilms (196, 197) . Proteome-wide tagging and labeling of bacterial proteins allow state-selective analysis and were applied to determine differences in predetermined proteins for planktonic and sessile bacterial species (198) . Another example of NMR-based applications for diverse systems involves total correlation spectroscopy (TOCSY)-NMR for the detection of solution and carbohydrate polymer components in S. epidermidis biofilms (199) . Although NMR is a good choice for biofilm compositional study, in the case of full matrix analysis and determination of the actual composition of biofilm carbohydrate components MS is usually applied due to the need for derivatization into monosaccharides.
IMAGING MODALITIES TO VISUALIZE COMMUNITY ARCHITECTURE
Evolving imaging modalities have contributed to significant improvements in spatial and temporal characterization of biofilms themselves and the signaling factors that alter bacterial behavior within the host-biofilm microenvironment (Table 2) .
Optical Microscopy
Fluorescence in situ hybridization (FISH) utilizes nucleic acid probes that bind to cRNA or DNA sequences within individual bacterial cells, enabling visualization of the spatial distribution of multispecies biofilms by use of specific probes (16S or 23S rRNA) along with epifluorescence microscopy. The targets are independent of cell metabolism levels, so FISH detects all viable microorganisms, including unculturable ones (200) . Peptide nucleic acids (PNA) exhibit higher target specificity and better hybridization kinetics. PNA FISH is versatile in clinical microbiology and biofilm investigations, in combination with confocal laser scanning microscopy (CLSM), offering species identification, spatial information, and bacterial load determination within mixed-species biofilms in chronic wound specimens and CF sputum (201, 202) . On the other hand, immunofluorescence (IF) assay employs fluorescently labeled antibodies that bind to specific target antigens and detect cell types or cellular subcomponents defining expression at biofilm developmental stages (203) .
The use of specific fluorescent probes has enhanced the specificity of CLSM for protein quantification and localization within colony biofilms. The structural complexity of the microbial polysaccharides confers a significant limitation on the use of labeled probes (45, 204, 205) . Fluorescent probes (dextrans, rhodamines, and Oregon Green) and fluorescence correlation spectroscopy (FCS) combined with CLSM enable biofilm diffusion quantification and thickness evaluation. These provide information on factors affecting antibiotic and biocide transportation within the biofilm microenvironment (206) . CLSM in combination with computational software can be extended to a multispectral and three-dimensional (3D) biofilm imaging and quantification technique. Digital analysis has replaced conventional qualitative and semiquantitative techniques with more accurate and sensitive procedures. Computer programs and software packages for biofilm visualization, quantification, and deconvolution (Imaris, COMSTAT, Amira, Volocity, ISA3D, ImageJ, and Fiji), containing structural variables including porosity, thickness and roughness coefficients, fractal dimension, and homogeneity, have been launched or belong in the public domain, thus providing analysis options (207) (208) (209) .
Structured illumination microscopy (SIM) enhances fluorescence abilities for 3D imaging of living cells (210) . Computational removal of out-of-focus light leads to true optical sectioning via exclusion of the associated blurred images (211) (212) (213) . 3D-SIM visualizes macromolecules interacting within the surrounding cellular environment.
Optical coherence tomography (OCT) offers real-time, 3D in vivo biofilm imaging ideal for biomass structure development and porosity identification. OCT enables nondestructive in situ biofilm analysis for chronic middle ear infection and dental biofilm growth monitoring (214, 215) . Doppler OCT imaging can be employed for quantitative biofilm dynamics analysis during the biofilm formation stages (216) .
Electron and X-Ray Microscopy
Transmission electron microscopy (TEM) offers a high resolution for visualizing specific structural components, such as polysaccharide fibrils and extracellular DNA. Combined with ruthenium red staining, TEM reveals the morphological features of bacterial cells within a fibrous matrix; such an example is the confirmation of the presence of P. aeruginosa biofilm in a burn wound animal model (204) . Scanning electron microscopy (SEM) is applied for biofilm structure and function (morphology, glycocalyx density, and layer thickness) analysis on living surfaces or inanimate materials. Compared to TEM, it is considered the optimal imaging tool, offering detailed, high-resolution 3D biofilm visualization (217) . Staphylococcus lugdunensis and Propionibacterium acnes causing implant-related osteomyelitis in an in vivo animal model were visualized by SEM analysis when present in intercellular aggregates within the bone marrow but not when localized intracellularly (218) .
Unlike SEM and TEM, environmental SEM (ESEM) retains visualization ability without laborious sample preparation and facilitates imaging of external cell polymers, though the spatial resolution is reduced compared to that of traditional SEM techniques (217, 219) . ESEM combined with energy-dispersive X-ray spectroscopy (EDS) has been employed for determination of the Proteus mirabilis biofilm composition on infected urinary catheters (219) . Finally, cryo-SEM is optimal for fragile, fully hydrated samples, offering ultrafast freezing as an optimal method of nonsolid specimen fixation (220) . When biofilms from diabetic foot wounds were investigated using SEM, a high level of resolution and detail was obtained, but the exopolymer matrix was destroyed during sample preparation. This limitation was overcome by the application of ESEM or cryo-SEM due to preservation of the biofilm hydrated state (221) .
The recent discovery that ionic liquids provide clear SEM-based visualization of biofilms from fully hydrated biological samples has opened new ways for broad SEM utilization (222) . Additionally, the method of immersed atmospheric SEM (ASEM), combining heavy metal labeling, charged nanogold labeling, and immunolabeling, enabled visualization of nanostructures of the biofilm-surface interface in liquids (223) .
Scanning transmission X-ray microscopy (STXM) provides data on spatial distribution as well as quantitative and qualitative analyses of biofilm components, thus dissecting the heterogeneity of microbial communities (224) . For example, multispecies microbial consortia have been investigated by STXM for the analysis of selenium particle biotransformation (225) . In another application, a CLSM-STXM combination was used on pseudomonal biofilms tested with antimicrobial agents, such as chlorhexidine dihydrochloride, benzalkonium chloride, triclosan, and trisodium phosphate, to detect differences in cell density, spatial distribution, and membrane integrity (226) .
Scanning Probe Microscopy and Imaging Mass Spectrometry
Atomic force microscopy (AFM) has gained increased attention due to its microbial cell surface structural and physical probing ability (227, 228) . AFM applications involve visualization of the biofilm structure and detection of the physicochemical interactions (van der Waals and electrostatic forces) between microbial cells and various surfaces (229) . For example, an AFM-mediated investigation of P. aeruginosa biofilm formation and adhesion on surface substrates, including sheets of aluminum, steel, rubber, and polypropylene, indicated that the polypropylene substrate's rough surface exhibited enhanced bacterial adherence compared to that on steel (230) . Confocal resonance microscopy (CRM) determines chemical differences among bacterial species. This technique can be used to map distributions of biomass, EPS, chemical components, and molecular compounds (231) .
Matrix-assisted laser desorption ionization-imaging mass spectrometry (MALDI-IMS) provides the spatial molecular distribution for each identified molecule within the biomass (24). IMS generates a wealth of data for developing "chemical fingerprint"
databases that enable chemical definition of colonies between bacterial species as well as discrimination of the subpopulations within biofilms (50, 232, 233). MALDI-IMS was used on single-species UPEC biofilms in order to analyze differences in the spatial proteome of adhesive fibers that confer virulence and biomass growth. Phase variation of the promoter of fim, encoding type 1 pili, was found to be under the control of oxygen availability (24).
Secondary ion mass spectrometry (SIMS) constitutes a label-free imaging methodology providing the highest depth and spatial resolution (234, 235) . Unlike MALDI-IMS, SIMS does not require the use of a matrix to get spatial information. When complemented with MALDI and CRM, this method provides identification and specific locations of proteins and other chemical species, macroscopic and cell-level chemical differences, mass-based discrimination of similar molecules, and the spatiotemporal distribution of metabolites and signaling molecules, even for multispecies biofilms (234) (235) (236) . For example, the chemical heterogeneity and secondary metabolites, such as rhamnolipids or quinolones, participating in biofilm growth and cellular signaling of a P. aeruginosa wild-type strain and an isogenic QS mutant were investigated by MALDI-SIMS, providing in situ chemical mapping (234) .
The future of biofilm visualization requires (i) in situ imaging of fully hydrated biological specimens, with avoidance of biofilm-destructive procedures; (ii) defined probes that enable a combination of imaging techniques for better resolution and 3D structure and/or microscopy that does not require probes (OCT or magnetic resonance imaging [MRI]); and (iii) updated software tools to meet the demands for enhanced digital biofilm imaging analyses (209) .
MODELING BIOFILMS EX VIVO
Ex vivo models involve biofilm growth on natural tissue in a minimally altered environment, offering more strictly controlled experimental conditions for extensive research than those of in vivo models (5). They facilitate the study of the association between biofilm formation and virulence or determinants of pathogenicity. These models contribute to the development of effective imaging tools that can monitor tissue-specific bacterial establishment. For example, porcine skin explants infected with S. aureus and P. aeruginosa have been used for the growth of mature biofilms that mimic chronic skin wounds and provide a way to assess antibiofilm antibiotic efficacy (237) .
Implants and medical devices enable biofilm formation that results in chronic infection. An ex vivo whole-blood model of S. epidermidis prosthetic joint infection was employed to elucidate the association between complement C5a levels and PIA-related biofilms as one of the main components of biofilm accumulation (238) . An ex vivo model of MG63 human osteoblasts cocultured with S. epidermidis strains was used to examine whether infection-related isolates exhibit adherence and internalization abilities different from those of commensal isolates. Flow cytometry, BRT, and CV assays were combined to test this hypothesis, which showed no statistically significant difference compared to studies on the harboring and expression of virulence factors that efficiently discriminate invasive strains from commensals (110, 239) .
Ex vivo models are also useful for assessing therapeutic windows of antibiofilm experimental treatments. A 3-day tolerant S. aureus biofilm grown on a porcine skin explant model was no longer detectable after treatment with a surfactant-based wound dressing, whereas biofilms wiped with moistened gauze reoccurred (240) . In a similar model, biofilms formed within the first 24 h were found to be more susceptible to antibiotics than mature formations, validating current therapeutic strategies that aim at early wound prophylaxis (241) . Similarly, porcine skin models have been used to test the effect of negative-pressure wound therapy with instillation on P. aeruginosa biofilms as well as the influence of tetracycline release of a zein and poly--caprolactone (zein/PCL) fibrous dressing on S. aureus biofilms (242, 243) . The comparative efficacy of glycine and tricalcium phosphate (TCP) over that of glycine or sodium bicarbonate in biofilm removal was examined by use of an ex vivo model using biofilms grown on titanium (Ti) and zirconium (Zr) implant surfaces (244) . The effects of topical treatments and commonly used antimicrobial dressings on biofilms of different maturation levels were also tested (237, 245) .
Cardiac valves constitute a substratum for in vivo clinical biofilms, highlighting the need for an ex vivo study model. An ex vivo model of porcine cardiac valve tissue combined with electron microscopy was used to examine the effects of the aggregation substance (Asc10) protein of E. faecalis on biofilm formation and persistence in endocarditis. It was found that Asc10 increased cell aggregation, leading to accelerated biofilm formation (246) .
The murine respiratory pathogen Mycoplasma pulmonis was recently used for biofilm development of a tracheal epithelium organ-mounting system that can be scanned with a fluorescence microscope, resulting in the observation that in vitro and ex vivo biofilms share common structural features and characteristics (247) . In a similar way, an ex vivo pig model of bronchiolar tissue infected with P. aeruginosa, resembling the CF lung mucus environment, provides a realistic and replicable HT assay to study the structure as well as virulence and physicochemical traits present in chronic biofilmassociated lung infections (248) .
The otitis, nasal, and throat mucosal biofilm formation models are further substrates for ex vivo biofilm model applications (249) . An ex vivo model of stainless steel tympanostomy tubes inoculated with P. aeruginosa and S. pneumoniae combined with SEM was used to examine biofilms formed on clearance of mucoid plugs after ofloxacin challenge (250) . Moreover, consecutive lavage samples of otitis media biofilms revealed the presence of NTHi subpopulations with different growth rates and gene expression modes (251) . In the case of the oral cavity, an ex vivo root canal model was applied to test the parameters influencing the efficacy of irrigation in biofilm removal, utilizing marketed fibronectin-and collagen-based films (252, 253) .
In a GI biofilm study, the pathogenicity of Aeromonas caviae strains isolated from human feces was investigated by use of an ex vivo rabbit ileal and colonic mucosa model. Cultured tissue was used for adhesion assessment of A. caviae strains (incubated with colonic and ileal intestinal fragments), whereas microscopy generated information regarding colonic and ileal mucosa colonization and biofilm formation (254) .
A porcine vaginal mucosal model (PVM) aimed to investigate the interactions among the commensal vaginal Lactobacillus spp., the anaerobic species Gardnerella vaginalis, and the sexually transmitted organism Neisseria gonorrhoeae, as well as the mechanisms of biofilm formation. The model quantified and unraveled different profiles for the effects of pH, acids, and Lactobacillus crispatus on G. vaginalis and N. gonorrhoeae growth when a live vaginal mucosal surface was used (255) .
DISSECTING BIOFILMS IN VIVO
The urgent need to investigate biofilm-associated infections and develop effective therapeutic strategies gave birth to translational approaches that allow the dissection of virulence and pathogenicity determinants and the identification of novel therapeutic targets. The widespread host-based models simulating biofilm-related mammalian diseases (Fig. 4) are discussed below.
Nonvertebrate Animal Models
Exploiting nonvertebrate animal models has provided an important solution to the need for investigations of biofilm-associated infections. The fruit fly (Drosophila melanogaster), the wax moth (Galleria mellonella), and the nematode worm (Caenorhabditis elegans) have historically been used to evaluate microbial virulence traits involved in mammalian infections and to test the efficacy of antimicrobial compounds (256) (257) (258) (259) (260) (261) (262) . These studies have elucidated factors affecting virulence, pathogenicity, and host immune responses by altering gene expression, studying efflux systems, toxins, or QS compounds, and allowing easy measurement of the host mortality (263-270) . The majority of pathogenic assays using these invertebrate models, by design, detect survival rates despite the wealth of microscopy and molecular methodologies that are often employed as surrogates for intensive interrogation.
Drosophila is extensively used to model wound or epithelial infections by Gramnegative bacteria, and comprehensive methodology exists for modeling persistent colonization and for assays of persister cell formation (271) (272) (273) . For the adult fly, the infection methodology includes (i) needle pricking (mimicking wound infection), (ii) feeding (mimicking oral infection methods), and (iii) injection pumping (mimicking a systemic infection similar to bloodstream infection in mammals). Larvae are less commonly infected than adults with either the feeding or injection pumping method (271) (272) (273) .
Innate host responses in Drosophila against P. aeruginosa are largely conserved in humans (274) (275) (276) . It was also demonstrated that there is a remarkable conservation in the virulence factors used by bacteria to infect both Drosophila and mammals (277, 278) . Drosophila models remain valuable tools for exploring biofilm molecular determinants; two adherence factors required for in vivo virulence of Pseudomonas fluorescens are (i) gmd, encoding the enzyme GDP-mannose dehydratase, involved in the synthesis of A-band-O-antigen-containing lipopolysaccharide (LPS); and (ii) a fadL homologue involved in long-chain-fatty-acid transport (279) . D. melanogaster has served as a model for the study of the functional correlation of the paraoxonase family members with biofilm formation and QS in vivo. This correlation has shown the protective role of the human enzyme paraoxonase 1 (PON1) in innate immunity (280) . Finally, Drosophila as an infection model of P. aeruginosa biofilms has provided a direct or indirect model of virulence and pathogenesis determinants through comprehensive analysis of the molecular responses of hyper-and low-biofilm-forming strains (281) .
The fly has also proven valuable for modeling of biofilm formation by Providencia spp.; it was identified that Providencia sneebia is lethal while propagating in the fly but elicits a mild immune response (282) . Moreover, a chronic gut Yersinia pestis infection was established in the anterior fly larva midgut to mimic and dissect the relationships between biofilm-associated genes (PhoP, GmhA, and OxyR), the gut immune system, and antimicrobial peptides (283) .
Galleria mellonella, a worm with a complex immune system, provides a competitively advantageous alternative to other hosts regarding size and amenability for the evaluation of antimicrobial treatments (284) . The infection development model employs larval caterpillars (third-or final-instar stage) that are injected with bacteria in the hemocoel via the last left proleg (285) . The wax moth has (i) facilitated screening of a U.S. Food and Drug Administration-approved library to identify antibiofilm compounds against Francisella novicida (286); (ii) been used to model biofilm formation by Acinetobacter baumannii, Burkholderia cepacia, Burkholderia multivorans, Campylobacter spp., and species in polymicrobial infections, such as the P. aeruginosa Liverpool epidemic strain and oral streptococci (287) (288) (289) (290) (291) (292) ; and (iii) been applied for evaluation of the antibacterial and antibiofilm activities of alternative therapeutic strategies against a multitude of pathogens, including S. aureus, MSSA, MRSA, and Acinetobacter baumannii (293) (294) (295) .
The free-living nematode C. elegans has been used to model infections by most Gram-negative bacteria, including E. coli, Burkholderia pseudomallei, B. cepacia complex (BCC), P. aeruginosa, and Yersinia pseudotuberculosis, through the feeding methodology (296) (297) (298) (299) (300) . The C. elegans-BCC interaction studies provided insights into the identification of the roles of specific biofilm-related virulence factors, including (i) the autoinducer-dependent acyl-homoserine lactone (aidA), (ii) the phenazine biosynthesis regulator (pbr), and (iii) the host factor phage Q (hfq) surface-associated lipoproteins (261, (301) (302) (303) (304) (305) (306) (307) .
A few reports involve less common invertebrate hosts for modeling of biofilm infections, such as (i) the ciliated protozoan Tetrahymena pyriformis for Legionella sp. and K. pneumoniae biofilms, (ii) the amoebae Acanthamoeba spp. for Legionella sp. and nontuberculous mycobacterium (NTM) biofilms, and (iii) the soil-living amoeba Dictyostelium discoideum for A. baumannii, Legionella sp., P. aeruginosa, and S. aureus biofilms (308) (309) (310) (311) (312) (313) (314) . There have been attempts to employ plants, such as the duckweed Lemna minor and the wounded alfalfa Medicago sativa, to allow biofilm growth of Burkholderia cenocepacia and S. enterica (315) (316) (317) . Arabidopsis thaliana (thale cress) is a popular tool in plant molecular biology that has been utilized as a host system to study B. subtilis and P. aeruginosa biofilm formation (318, 319) .
Vertebrate Animal Models
Vertebrate animal models have been used extensively to mimic human biofilm infections and to test antimicrobial efficacy (320, 321) . Localized mammalian animal models may refer to skin and soft tissue infections experimentally studied by use of infected excisional wounds, partial-thickness abrasions, scratches, burns, abscesses, and surgical sites. Apart from the pathogen of interest, experimental variation can also include the mammalian host by alteration of its immunological state (5, 266, (321) (322) (323) (324) (325) (326) (327) (328) (329) (330) (331) (332) (333) (334) (335) (336) (337) (338) . Here we include some examples from the literature which underline the recent efforts and achievements in the field of vertebrate-based biofilm formation and evaluation.
The optically clear zebrafish, Danio rerio, has been applied for P. aeruginosa biofilm imaging and for biofilm formation quantification of the bacterial fish pathogen Edwardsiella tarda and the pig pathogen Streptococcus suis (339) (340) (341) (342) . Zebrafish has also been used to study Mycobacterium haemophilum and to evaluate oral pathogen adhesion in a vertebrate orointestinal model (343, 344) .
Mouse model biofilm formation has been described for (i) a multidrug-persistent A. baumannii murine wound infection to evaluate therapeutic solutions against trauma and surgical infections in hospitalized patients (345) and (ii) BALB/c and C3H/HeN mice to study chronic P. aeruginosa wound infection establishment after a third-degree burn with skin necrosis (346) .
Reports for in vivo porcine skin infection models are surprisingly scarce given, for example, the MRSA-associated skin wound model that examines the effective bacterial load reductions of various methods of debridement (hydrosurgery and plasmamediated bipolar radiofrequency ablation) (347) . Antimicrobial photodynamic therapy (aPDT) has been applied against a variety of pathogens implicated in acute and chronic biofilm-associated infections. In order to test the efficacy of photosensitization, various animal models have been applied. Mouse, rat, and pig wound, osteomyelitis, and arthritis models as well as dog dental infection models revealed the therapeutic potential of PDT against pathogens, including streptococci, MSSA, MRSA, P. aeruginosa, A. baumannii, P. gingivalis, and Fusobacterium nucleatum (322) (323) (324) (325) (326) (327) .
Rat models are in constant use due to their amenability to wound and infection site colonization without the requirement of disturbing factors (foreign bodies or diabetes mellitus induction), allowing a correlation with rat age, location of the wound, and size of the inoculum (348) . Mouse models employing tissue cages and catheter infection can provide information about the antimicrobial efficacy of biomaterial coatings and host-pathogen interactions (349, 350) . In the field of implanted device-associated infections, a major model involves totally implantable venous access ports (TIVAPs) implanted in rats. This model allows monitoring of bacterial biofilm development, physiology, and prevention strategies by use of inocula of four bioluminescent pathogens, including S. aureus, S. epidermidis, E. coli, and P. aeruginosa (351) . Along with rat models, rabbits have also been used in prospective animal studies to investigate, for example, the effect of a 60-A implantable direct-current fusion stimulator on the implant-related infection rates in a postoperative spinal wound infection model. All sites were inoculated with MSSA, but no significant difference was observed for the implant and bone infection rates and the bacterial load (352) . Another observation found by use of an indwelling device rat model was the inhibitory effect of QS disruption via RNAIII-inhibiting peptide (RIP) on S. epidermidis infections (333) .
Titanium implants have been used to examine the inhibitory and prophylactic effects of gentamicin coatings on titanium oxide surfaces (bioactive TiOB) (353) . Likewise, murine osteomyelitis models have been developed to monitor immune responses occurring during S. aureus infection and healing (interleukin-4 [IL-4] and gamma interferon) following implant placement after bone fractures. A fracture fixation murine model employed skeletally mature C57BL/6 mice that were treated with Ti fracture fixation plates and screws after femur osteotomy (354) . A rat model of acute foreign-body osteomyelitis was used to evaluate the role of the E. faecalis ahrC and eep genes in biofilm formation and virulence. Stainless steel orthopedic wires were inoculated with E. faecalis OG1RF ⍀ahrC and Δeep isogenic mutants and implanted into the proximal tibiae of rats (355) . In an S. aureus-associated murine osteomyelitis model, a fixation plate was employed for debridement of the fracture during a revision surgery, followed by the placement of a vancomycin-laden implant. Infection monitoring was achieved via bioluminescence imaging, X-ray, and micro-computed tomography (CT) for the evaluation of both osteolysis and bone formation (328) .
An implantable-cage MRSA infection model using male albino guinea pigs was developed, and treatment efficacy against planktonic and biofilm infections was evaluated for the most commonly prescribed antimicrobial agents. Antimicrobial testing concluded with an optimal combination of fosfomycin and rifampin against implantassociated MRSA infections (356) . Rabbits have also been used in models of spinal implant S. aureus infections to assess the antimicrobial potential of modified Ti pedicle screw coatings as well as the efficacy of front-line antistaphylococcal drugs (357, 358) .
The majority of models developed for the study of gastrointestinal colonization and biofilm formation are murine, with an emphasis on colitis. One of these mouse models identified the importance of the stringent response regulator DksA for Salmonella pathogenicity, virulence, and biofilm formation. During early stages of S. Typhimurium infection, DksA is induced at the murine midcecum and is required for systemic infection (359) . Likewise, the contribution of other bacterial species to early GI colonization was proved by use of a Clostridium difficile colon and cecum mucus mouse model with FISH application (360) . A notable reported intestinal model involves evaluation of Shigella flexneri adhesiveness in the guinea pig gut. Deficient LPS inner core biosynthesis presented by the ΔrfaC mutant resulted in enhanced biofilm formation on and adhesion and invasiveness to human epithelial cells, an observation that could be utilized for the development of new therapeutics. It was also concluded that fitness gains through host adhesion and strong biofilm formation did not replace the effect of fitness loss due to LPS deletion on survival rates (361) .
Mouse models have also been applied to mimic biofilm-associated UTIs as well as to evaluate the correlation between host immune systems and local defense factors, the attributed infection (nephron obstruction and pyelonephritis), and treatment (362) . Future UTI models may utilize human-mouse chimeras based on severe combined immunodeficient (SCID)-hu mice in order to achieve a better match with human conditions (321) .
P. aeruginosa is of utmost importance in chronic lung infection, and efforts to reveal the relationships between the vertebrate host and virulence factors are long-standing (329) . A murine inhalation model was developed to connect chronic P. aeruginosa nasopharyngeal carriage with lung infection, which complicates and increases resistance to therapeutic agents (363) . In a P. aeruginosa and S. aureus coinfection mouse CF model, P. aeruginosa isolates were found to outcompete S. aureus at early stages of chronic infection (364) . Moreover, the therapeutic potential of inhaled liposomal amikacin was tested in a P. aeruginosa rat lung infection model (330) . P. aeruginosa biofilms formed on murine tumors have also been used to examine the efficacy of ciprofloxacin, colistin, tobramycin, and their combinations (331) .
Oral biofilms are a major chapter in biofilm-related literature, and the quest for animal models in closer proximity to humans leads to the exploitation of primates. In a screening effort to identify an optimal host for monitoring Aggregatibacter actinomycetemcomitans, the leading cause of periodontitis in humans, Macaca mulatta (rhesus [Rh] monkeys) ranked as the first choice. Rh monkeys provide an established oral habitat to validate A. actinomycetemcomitans-mediated periodontitis (365) . Rh monkeys have also been tested for age-mediated apoptosis gene expression in oral mucosal tissues. The transcriptomic analysis of apoptotic gene expression reflects decreased apoptotic phenomena in the oral mucosa of aging animals that consequently may increase dysregulation in anti-inflammatory responses and induce disease (366) .
A murine periodontitis model combined with genomics and quantitative PCR was used to examine the role of host factors in persistent subgingival biofilms (336) . Likewise, a rat model of A. actinomycetemcomitans-induced periodontitis was combined with RT-PCR for versatile applications, ranging from genetic reduction to therapeutic efficacy evaluation according to exopolysaccharide variations (367) . Another rat model, the in vivo extraradicular biofilm model, is more inclusive, as it may facilitate identification and quantification of biofilm-forming bacteria by use of real-time PCR (rt-PCR) and micro-computed tomography (368) . Chinchillas (Chinchilla lanigera) have been employed for study of middle ear infections in an attempt to establish realistic infection models, to overcome limitations in biofilm analysis, and to correlate the sequence of events in polymicrobial infections with the host immune system. A chinchilla otitis media model involving an NTHi 86-028NP isolate and an isogenic phosphorylcholine (PCho) transferase (licD) mutant was deployed to show that PCho facilitates biofilm stability and alleviates the host immune response, promoting NTHi infection and increased persistence (369) .
Biofilm treatment efficacy testing is a field that demands available surfaces and assays, and rabbits and guinea pigs have been tested toward this end. A rabbit otitis model examined the efficacy of a nanoporous middle ear implant coating releasing ciprofloxacin against P. aeruginosa (370). In another study, a guinea pig animal model combined with otoendoscopy, histology, and bone CT was used to examine the inhibitory effect of a vancomycin-eluting nanofiber mat against MRSA biofilms formed on ossicular prostheses and middle ear infections (371) .
Animal models offer insight into the interplay of basic biofilm features and host defense mechanisms (372) . However, the risk of coincidental assessment of the experimental conditions is high, and most mammalian models are considered not identical in effectively reproducing the major infectious entities within the human host (Fig. 4) .
IN VIVO IMAGING TOOLS
Bioluminescence imaging takes advantage of bacterial cloning vectors optimized to allow for the expression of luciferin in different bacterial cells (373) . As a result, these microbial cells "glow in the dark," and a sensitive imaging camera is able to capture images of small animals, revealing both the location and intensity of the infecting microorganisms in real time, in a noninvasive manner. This technology has dramatically reduced the number of animals needed to obtain statistically significant data on antimicrobial therapeutics (374) . Previously, animals were generally sacrificed at discrete time points, followed by tissue removal, homogenization, and CFU culture and enumeration. This has often left unanswered the question of what happens at later times, as many antimicrobial treatments are highly effective at early time points but the microbial cells regrow when the initial antimicrobial action has ceased (351, 375) . Scarce protocols examine the dynamic processes of biofilm formation, bacterial load, infection physiology, and response to treatment for in situ models of implantable devices. Bioluminescence combined with a totally implantable venous access port model has been used to assess localized and systemic infections related to CVC in rats, reproducing clinically significant situations of foreign body-associated infections (351) . These models have been valuable in the investigation of aPDT, which involves photosensitizing dyes topically applied to the infection site and subsequent harmless visible light illumination and reactive oxygen species (ROS) generation (324, 376) . Bioluminescence imaging of localized infections not only is well suited for monitoring the effectiveness of experimental antimicrobial therapeutics but also has a major role in the study of microbial virulence and pathogenicity. A virulence-specific study of an oral mouse infection model that employed a multiplexed biophotonic imaging-based inducible luciferase reporter was used to track individual species temporally and spatially in polymicrobial biofilms (377) . Bioluminescence technology has expanded to include imaging in three dimensions for biofilm infections that would otherwise be challenging to monitor and treat (378) (379) (380) (381) (382) .
Near-infrared fluorescence molecular probes have been delivered by local injection and used to visualize inflammation as well as implant-related biofilm infections in a rapid and minimally invasive manner, therefore aiming at detecting orthopedic-related infections (383) . The hydro-sulfo-Cy5 probe detects ROS generation following bacterium-free or biofilm-containing implant application. On the other hand, diaminocyanine sulfonate was used to detect ad hoc biofilm-associated nitric oxide production (384) .
The dye C-SNARF-4 coupled with ratiometric imaging allowed 3D visualization in real time of the extracellular pH variation in the growth of dental biofilms (385) . Ligand-targeted ultrasound contrast agents (UCAs) coupled with optical and highfrequency acoustic microscopy have facilitated detection, visualization, and quantification of S. aureus biofilm matrices in both test tube and animal model adjusted surface cultures (386) . Noninvasive 3D OCT can be used to identify as well as visualize, in real time, in vivo bacterial microcommunities involved in biofilm-associated otitis media (387) . OCT has been coupled with low-coherence interferometry to image the biofilm layer on the sensitive, ultrathin tympanic membrane in the middle ear (388) . Another optical technique, intraoral cross-polarization swept-source OCT (CP-OCT), provided an additional tool to visualize the in vivo density of the biofilm formed between the enamel and the interface (389) . Spatially resolved MRI was used to study structures within dynamic physical and chemical material systems, and also in biological systems, with a limited number of biofilm applications (390) . In an analogous fashion, micropositron electron tomography coupled with the radioactive probe [ 18 F]fluorodeoxyglucose was used to monitor S. aureus biofilm infections and antimicrobial therapy in a mouse model (391) .
Optical, radiographic, and CT imaging modalities have been used as tools to monitor orthopedic implant biofilm infections longitudinally, to assess the bacterial load, and to detect osteolysis (392) . Multiresolution imaging coupled with in vivo labeling uncovered the supplemental tasks of the matrix components of V. cholerae biofilms (393) . Maltodextrin-based imaging probes (MDPs), a family of light-emitting contrast agents chaperoned with maltohexaose, enable in vivo bacterial detection with paramount responsiveness through a cell-specific mechanism. MDPs are rapidly internalized through the maltodextrin transport pathway and selectively accumulate within bacteria at low concentrations, with enhanced specificity over that for mammalian cells (394) .
Finally, a bioluminescence-fluorescence combination containing a naturally lightemitting bioluminescent S. aureus strain and fluorescent neutrophils from an enhanced green fluorescent protein (EGFP)-expressing mouse strain (LysEGFP) was applied for visualization of a surgical site infection in the knee joint in a mouse model. In vivo bioluminescence imaging was used to quantify the microbial burden. Accordingly, in vivo fluorescence imaging was used to assess the neutrophil inflammatory response. In the same mice, bioluminescence and fluorescence optical imaging combined with CT imaging allowed for visualization of 3D anatomical details. This triple imaging combination was proposed to simultaneously track bone biofilm infections, including inflammatory responses and local anatomical modifications, in a noninvasive manner (381) .
SHAPING UP THE METHODOLOGICAL PIPELINE Literature Search on Method Implementation
Extensive electronic literature searches provided additional information on the current methodological landscape of biofilm research. Queries were conducted to search the literature from the first biofilm report in October 1988 through August 2017 by using the keywords "biofilm(s) and/or assay" (particularly involving the colorimetric assays applied in the lab) and "biofilm(s) and/or device" separately (Fig. 5) . Two specialized exceptions, for "microfluidics" ("bioflux" and "microfluidic device") and "Calgary" ("MBEC device" and "MBEC HT"), were introduced to the query search. Articles without an abstract or in a language other than English and papers with irrelevant content were excluded from the search process.
What we deduce from the graphical representation of biofilm-based methodology publications is that the number of research articles for assays is higher than that for devices, with an average ratio of 7 assay publications to 3 device publications and a statistically significant difference (P Ͻ 10 Ϫ4 ). It is also evident that in the approximately 30-year timeline of the query, methodologies are irregularly distributed, indicating a lack of consistency and approval. Figure 5 reveals that (i) the peg lid CBD-MBEC and microfluidics-based devices stand out, with a dynamic presence and increasing rates of use; (ii) the drip-flow cell reactors and rotating-disk reactors might be occasional choices for biofilm growth; (iii) the Kadouri system has remained an interesting alternative in the past decade; (iv) CV, XTT, Congo red, Live/Dead BacLight, and resazurin assays show continuously increasing rates of use; and (v) DAPI appears to be a less popular yet solid choice that never acquired a dynamic rate similar to those of the five major assays for biofilm viability assessment. Another interesting observation is that significant development of different technologies for both assays and devices took place between 2008 and 2015 (up to 12 different assays and 7 different devices). Although an exponentially growing number of assays and devices were developed and applied, only a few have prevailed. More specifically, CV, XTT, and Congo red assays were the predominant methodologies among assays, while the Bioflux, Calgary, and drip-flow technologies dominated among devices over the past 6 years. This observation leads us to the conclusion that experimentation in developing novel methodologies in the biofilm research area is declining and that most of the methods have been abandoned by the research community.
Through implementation of the same search criteria, 4.9% of the publication fraction is dedicated to biofilm techniques over biofilm research (1,839/37,833 publications). This percentage is extremely low, taking into consideration the gap in studying multispecies biofilms under realistic environmental or clinical conditions. In order to strengthen our result that the percentage of publications regarding biofilm techniques over biofilm research is low, we attempted to evaluate the publication fraction of another research area's methodological achievements. Genome editing is a large and promising area of research, leading the way toward exploring the potential of new developments by implementing a wide range of novel tools and techniques (395) . Interestingly, the methodologies applied in the study of genome editing, until September 2017, amounted to 23.4% (2,355/10,062 publications) of publications, with the following keywords used as queries in PubMed searches: ("genome editing" or "chromosomal editing" or "genome inversions" or "chromosomal inversions" or "genome translocation" or "chromosomal translocation" or "structural variations" or "engineered nucleases" or "nucleotide repeats" or "DNA repeats") and ("double-strand breaks" or "DSBs" or "zinc-finger nuclease" or "ZFN" or "transcription activator-like effector nuclease" or "TALEN" or "clustered regularly interspaced short palindromic repeats" or "CRISPR" or "CRISPR-associated protein 9" or "Cas9" or "RNA-guided engineered nuclease" or "RGEN").
The field of biofilm research has proved that the establishment and definition of a "perfect method" comprise a rather precarious generalization. Taking for granted the uniqueness of bacterial biofilms as vivid microcommunities, the approach of a "onesize-fits-all" methodology would abolish any attempt at a thorough understanding. Pluralism in available methodologies is instrumental in order to address basic questions about biofilm formation, structure, adherence, physiology, kinetics, and interactions with the host.
State-of-the-Art Methodologies in Biofilm Investigation
The majority of information that constitutes the current knowledge on biofilm formation patterns is based on in vitro studies. Combined technologies simulate biofilm growth and formation conditions. However, studying biofilms in the lab provides information which differs significantly from our experience in clinical practice. Such an observation defines the need for further experimental accuracy in order to link in vitro and in vivo outcomes. The host habitat, regarding immunity parameters as well as the components of the human body (tissues [acting as adherence surfaces] and body fluids, such as urine and blood), constitutes a challenging landscape for bacterial growth which differs from experimental conditions (396) . Some state-of-the-art compositions and devices have already entered the market over the last decade (Table 4) .
Biofilm growth detection based on molecular probes or staining agents enables direct observation, quantification, and topographical mapping of bacterial growth in vivo or on medical tool surfaces (397) (398) (399) (400) (401) (402) . A number of adherence assays exploit biofilm properties and detect biofilm formation and structure (403, 404) . Indwelling medical devices carrying color change indicators integrated in substrates prone to degradation in the presence of bacteria mediate detection when applied in vivo (405, 406) . Immunoassays and enzymatic methods certify biofilm presence and assist in quantification (407, 408) . Other in vivo theranostic devices employ imaging and sensing tools enabling biofilm "fingerprint" detection through data collection and analysis of thickness, growth speed, and physicochemical properties (409) (410) (411) (412) .
Combinatorial application of older and conventional methodologies for both in vitro and in vivo biofilm investigation constitutes a significant resource for the launch of cutting-edge tools. Enhancement of techniques by use of sensing modules, bioinformatics, and the inspirational introduction of biomaterials in surface construction have provided alternative insights into biofilm research. Where lies the difference between research lab methodologies and inventions? What is the clinical significance of the innovation landscape? Sum-of-the-parts comparative analysis gives answers regarding the differences between conventional methodologies and innovative tools. Commercially exploited staining methods differ from those applied in the academic or clinical lab, including a wider variety of biocompatible dyes offering a speedy and easy way to detect results. In-host commercial theranostic devices allow real-time information on the applicability and success rate of the technique right from the bedside. Finally, computational and biosensing methods embedded in daily routines, even adjusted to the size of a toothbrush, set the road for the development of devices that will eventually enter clinical settings.
Extending beyond Commonplace Platforms
Quartz tuning forks (QTFs) have been applied for P. aeruginosa biofilm growth monitoring and (bio)sensing (28, 413). The adhesion dynamics that determine biofilm development are monitored by use of piezoelectric tuning forks. QTFs also enable biomass growth detection as well as antibiotic testing and determination of nanomechanical surface properties (414) . A polyurethane-coated, magnetostrictive, ribbon-like sensor as part of a flow system connected to a bioreactor has been used to wirelessly monitor P. aeruginosa biofilm formation with the aid of magnetic field telemetry (415) . Electromagnetic (EM) wave sensors offer a reliable, real-time, cost-effective methodological tool for in situ P. aeruginosa growth analysis. EM wave sensors mounted on a polymethyl-methacrylate microfluidic cell structure contributed to the early detection of biofilm growth upon excitation at microwave frequencies (416) .
Chronicity due to AMR stems from the lack of detection methodologies for clinically relevant biofilms formed at an early stage. A shift in this reality would potentially support better treatment options. This concept was the foundation for development of a coupled optical and acoustic imaging technology that noninvasively detects and quantifies biofilm biomass. Ligand-targeted UCAs assessed the ability of S. aureus to form communities in vitro (386) . High-frequency scanning acoustic microscopy (SAM) coupled with UCAs facilitated ultrasonic imaging and quantification of the mechanoelastic biofilm properties. This method was proven to be efficient, though the similarity of biofilm acoustic impedance (1.9 MRayl) and that of human soft tissues (1.35 to 1.85 MRayl) poses a serious limitation to in vivo imaging.
Bacterial aggregates require specific spatial distribution and environmental parameters to develop physicochemical properties that confer clinically relevant phenotypes (virulence factor production, AMR, and biofilm formation) contributing to strain-specific pathogenicity (417) (418) (419) . The technical drawback of monitoring the behavior of these populations due to their small size (10 1 to 10 5 cells) was recently overcome by use of a laser-based lithographic technology that provides microscopic printing of the 3D geometry of the bacterial aggregates, along with scanning electrochemical microscopy (SECM) enabling redox-active, biofilm-derived small-molecule quantification (for example, that of pyocyanin from P. aeruginosa) (420) (421) (422) . Coupling of these two analytical tools achieves real-time quantitative monitoring of bacterial aggregate interplay and assesses the impacts of spatial organization and chemical signaling on sociomicrobiology.
Extending the use of 3D printing technologies, a novel material consisting of the broad-spectrum antibiotic nitrofurantoin and the biodegradable polymer poly(L-lactic acid) was manufactured to mimic catheters. The 3D-printed disks exhibited Ͼ85% biofilm inhibition; therefore, an antimicrobial option has emerged for medical device coatings (423) . One of the most recent setups for real-time E. coli and P. aeruginosa biofilm biomass growth evaluation was achieved through a sensing microsystem in which a microfluidic flow reactor employs a surface acoustic wave (SAW) sensor and electrodes constituting a source for current signals. This electric field is coupled with the use of gentamicin, and therefore this integrated sensing platform serves for biofilm growth monitoring and biofilm elimination (424) . A novel impedimetric sensing system based on the interdigitated microelectrode microsystem envisions paving the way for the development of smart biosensors for rapid implant-associated biofilm identification and removal. In short, this microsystem allows label-free E. coli biofilm growth detection in microfluidic channels by evaluating the fractional relative change in real time as well as monitoring the threshold-activated bioelectric effect on the in situ treatment process (425) . A custom-made surface plasmon resonance (SPR) biosensor was recently applied for E. coli biofilm formation investigation on gold-plated glass disks. In particular, the angle-based SPR biosensor allowed real-time capture of the SPR curve as well as calculation of the refractive index change, thus offering a complete picture of the biofilm formation cycle (426) .
CONCLUDING REMARKS
It is evident that most experimental biofilm procedures provide descriptive and quantitative information, but combining tools and methods unravels more pieces of the puzzle. Most of the conclusions obtained here are derived from in vitro studies, yet their relevance to the processes and methodologies occurring in vivo are a subject for further consideration and experimentation. Recalcitrant and persistent biofilm-associated diseases have raised the need for new therapeutic approaches and methods for reliably culturing mature biofilms and evaluating their chemical, structural, and physiological characteristics.
The lack of consistent and robust animal biofilm models is perhaps the most critical element missing from the equation. It appears that engineering-driven approaches give and will continue to give methods and tools transcending the current norm and status of biofilm analysis. This pool is still in the periphery of clinical knowledge. Thus, the fundamental questions remain partially answered. That is, how do we detect biofilm formation at the bedside, and what is the best course of action for eradication? Commercially available kits and the wealth of research information can educate but barely provide comprehensive and articulated answers. A more compelling set of answers may arise when the intersection of clinical and engineering approaches becomes relevant.
Advances regarding the microbiome and unculturable bacteria designate the imperative need for reliable tools for thorough investigation of host-biofilm interactions. Consequently, the establishment of robust biofilm susceptibility assays also remains a challenge for clinical entities. Information stemming from combinatorial assays may provide comprehensive and critical insights into any given biofilm-associated clinical query. 
